Merz Pharmaceuticals establishes joint venture in Brazil
Clients Merz GmbH & Co. KGaA
Jones Day advised Merz Pharmaceuticals GmbH, a wholly owned subsidiary of Jones Day's long standing client Merz GmbH & Co. KGaA, on the establishment of a joint venture in Brazil. Merz' joint venture partner is Biolab Farmacêutica, one of Brazil's leading pharmaceutical companies. Biolab has been marketing some of Merz' products for quite some time in Brazil. The joint venture now agreed, in which Merz will have a 61% stake, will give Merz direct access to Brazil's growing market for pharmaceutical and aesthetical products.